Ask what Korea is talking about.

From today, South Korea permits people who legally purchased weight-loss drugs overseas to bring in up to a three-month supply, Yonhap reports. The move comes as the Ministry of Food and Drug Safety issued a safety alert Wednesday over a rare vision-loss risk linked to GLP-1 obesity drugs, including popular treatments, according to the Korea Times. A separate Korea Times report from October said one in 10 Korean adults used or was prescribed obesity drugs such as Wegovy and Mounjaro in the past year, with younger generations reporting higher usage and one-third of respondents saying they would use such drugs in the future.